Nella revisione Cochrane del 2011, relativa a 2 studi su 3477 pazienti asiatici, quelli trattati con cilostazolo avevano un minor rischio di eventi vascolari globali (NNT 38)ed un più basso rischio di ictus emorragico e di eventi avversi (NNT 66 e 31). Sono necessari nuovi studi per valutare la possibilità che il cilostazolo sia ugualmente efficace anche in soggetti di razza non asiatica.
Tags
Segreteria Organizzativa e Coordinamento Generale
Pierrel Research Italy
Via Alberto Falck, 15
20099 Sesto San Giovanni (MI)
Tel: +39 02 24134.260
Fax: +39 02 24862994
e-mail: info@spread.it
Con il contributo di
6a-2010
Sintesi 12-13
Vai al volume: 12.12.3 Placche dell’arco aortico
Le placche presenti a livello dell’arco aortico sono un predittore importante nell’insorgenza di stroke.
Voce bibliografica VonBardelebenRS,2009 capitolo 12
12.VonBardelebenRS,2009 - Von Bardeleben RS, Richter C, otto J, Himmrich L, Schnabel R, Kampmann C, Ruprecht HJ, Marx J, Hommel G, Munzel T, Horstick G.
Von Bardeleben RS, Richter C, otto J, Himmrich L, Schnabel R, Kampmann C, Ruprecht HJ, Marx J, Hommel G, Munzel T, Horstick G. Long term follow up after percutaneous closure of PFO in 357 patients with paradoxical embolism: difference in occlusion sytems and influence of atrial septum aneurysm. Int J Cardio 2009;134:33-41.
Voce bibliografica Alsheikh-AliAA,2009 capitolo 12
12.Alsheikh-AliAA,2009 - Alsheikh-Ali AA, Thaler DE, kent DM.
Alsheikh-Ali AA, Thaler DE, kent DM. Patent foramen ovale in cryptogenic stroke: incidental or pathogenic? Stroke 2009;40(7); 2349-2355.
Voce bibliografica HandkeM,2007 capitolo 12
12.HandkeM,2007 - Handke M, Harloff A, Olschewski M, Hetzel A, Geibel A.
Handke M, Harloff A, Olschewski M, Hetzel A, Geibel A. Patent foramen ovale and cryptogenic stroke in older patients. J N Engl Med 2007;357:2262-2268.
Voce bibliografica OverellJR,2000 capitolo 12
12.OverellJR,2000 - Overell JR, Bone I, Lees KR.
Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a metanalysis of case-control stydies. Neurology 2000;55:1172-1179.
Voce bibliografica DiTullioMR,2007 capitolo 12
12.DiTullioMR,2007 - Di Tullio MR, Sacco RL, Sciacca RR, Jin Z, Homma S.
Di Tullio MR, Sacco RL, Sciacca RR, Jin Z, Homma S. Patent foramen ovale and the risk of ischemic stroke in a multicentric population. J Am Coll Cardiol 2007;49:797-802.
Voce bibliografica PettyGW,2006 capitolo 12
12.PettyGW,2006 - Petty GW, Khandheria BK, Meissner I, Whisnant JP, Rocca WA, Christianson TJ, Sicks JD, O’Fallon WM, McClelland RL, Wiebers DO.
Petty GW, Khandheria BK, Meissner I, Whisnant JP, Rocca WA, Christianson TJ, Sicks JD, O’Fallon WM, McClelland RL, Wiebers DO. Population-based study of the relationship between patent foramen ovale and cerebrovascular iscgemic events. Mayo Clin Proc 2006;81:602-608.
Voce bibliografica MeissnerI,2006 capitolo 12
12.MeissnerI,2006 - Meissner I, Khandheria BK, Heit JA, Petty GW, Sheps SG, Schwartz GL, Whisnant JP, Wiebers DO, Covalt JL, Petterson TM, Chriastianson TJ, Agmon Y.
Meissner I, Khandheria BK, Heit JA, Petty GW, Sheps SG, Schwartz GL, Whisnant JP, Wiebers DO, Covalt JL, Petterson TM, Chriastianson TJ, Agmon Y. Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. J Am Cardiol 2006;47:440-445.
Voce bibliografica GrahamDJ,2010 capitolo 12
12.GrahamDJ,2010 - Graham DJ, Quellet-Hellstrom R, Macurdy TE, Ali F, Sholley C, Worall C,Kelman JA.
Graham DJ, Quellet-Hellstrom R, Macurdy TE, Ali F, Sholley C, Worall C,Kelman JA. Risk of acute myocardial infarction, stroke, heart failure, and death in elderly medicare patients treated with rosiglitazone or pioglitazone. JAMA 2010 Jun 28.
Voce bibliografica PatelMR,2011 capitolo 12
12.PatelMR,2011 - Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM; ROCKET AF Investigators.
Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM; ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011 Sep 8;365(10):883-91).
Voce bibliografica KamalAK,2011 capitolo 12
12.KamalAK,2011 - Kamal AK, Nagyi I, Husain MR, Khealani BA.
Kamal AK, Nagyi I, Husain MR, Khealani BA. Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin. Cochrane Database Syst Rev 2011 Jan 19(1):CD008076.
Raccomandazione 12.13 d 
Vai al volume: 12.11.2 FOP ed embolia paradossa
Nei pazienti con recidiva di ictus o TIA associato a FOP, in presenza di trattamento con ASA o con TAO, dopo una rivalutazione multidisciplinare del caso e in accordo con il paziente è indicata la chiusura del PFO.
Voce bibliografica RabadiMH,2008 capitolo 11
11.RabadiMH,2008 - Rabadi MH, Coar PL, Lukin M, Blass JP.
Intensive nutritional supplements can improve outcomes in stroke rehabilitation. Neurology 2008; 71(23):1856-61
Archivio PDF della 6a edizione 2010
Da questa pagina è possibile scaricare la sesta edizione (Stesura del 7 gennaio 2010) delle Sintesi e Raccomandazioni SPREAD.
Voce bibliografica Heald,2006 capitolo 06
6.Heald,2006 - Heald CL, Fowkes FGR, Murray GD, Price JF
Heald CL, Fowkes FGR, Murray GD, Price JF. Risk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review. Atherosclerosis 2006; 189: 61– 69.
Voce bibliografica Diehm,2009 capitolo 06
6.Diehm,2009 - Diehm C, Allenberg JR, Pittrow D, Mahn M, Tepohl G, Haberl RL, Dairus H, Dipl-Math IB, Trampisch HJ
Diehm C, Allenberg JR, Pittrow D, Mahn M, Tepohl G, Haberl RL, Dairus H, Dipl-Math IB, Trampisch HJ. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation 2009; 120: 2053–2061.
Voce bibliografica Langhorne,2009 capitolo 18
18.Langhorne,2009 - Langhorne P, Coupar F, Pollock A
Langhorne P, Coupar F, Pollock A. Motor recovery after stroke: a systematic review. Lancet Neurol 2009; 8: 741-754.
Voce bibliografica Ragert,2008 capitolo 18
18.Ragert,2008 - Ragert P, Vandermeeren Y, Camus M, Cohen LG
Ragert P, Vandermeeren Y, Camus M, Cohen LG. Improvement of spatial tactile acuity by transcranial direct current stimulation. Clin Neurophysiol 2008; 11: 805-811.
Voce bibliografica Boggio,2007 capitolo 18
18.Boggio,2007 - Boggio PS, Nunes A, Rigonatti SP, Nitsche MA, Pascual-Leone A, Fregni F
Boggio PS, Nunes A, Rigonatti SP, Nitsche MA, Pascual-Leone A, Fregni F. Repeated sessions of noninvasive brain DC stimulation is associated with motor function improvement in stroke patients. Restor Neurol Neurosci 2007; 25: 123-129.
Voce bibliografica Fregni,2005 capitolo 18
18.Fregni,2005 - Fregni F, Boggio PS, Mansur CG, Wagner T, Ferreira MJ, Lima MC, Rigonatti SP, Marcolin MA, Freedman SD, Nitsche MA, Pascual-Leone A
Fregni F, Boggio PS, Mansur CG, Wagner T, Ferreira MJ, Lima MC, Rigonatti SP, Marcolin MA, Freedman SD, Nitsche MA, Pascual-Leone A. Transcranial direct current stimulation of the unaffected hemisphere in stroke patients. Neuroreport 2005; 16: 1551-1555.
Voce bibliografica Takeuchi,2008 capitolo 18
18.Takeuchi,2008 - Takeuchi N, Tada Takeo, Toshima Mashahiko, Chuma Takayo , Matsuo Yuichiro, Ikoma Katsunori
Takeuchi N, Tada Takeo, Toshima Mashahiko, Chuma Takayo , Matsuo Yuichiro, Ikoma Katsunori: Inhibition of the unaffected motor cortex by 1Hz repetitive transcranial magnetic stimulation enhances motor performance and training effect of the paretic hand in patients with chronic stroke. J Rehabil Med 2008; 40: 298-303.
Voce bibliografica Khedr,2009 capitolo 18
18.Khedr,2009 - Khedr EM, Etraby AE, Hemeda M, Nasef AM, Razek AAE
Khedr EM, Etraby AE, Hemeda M, Nasef AM, Razek AAE. Long-term effect of repetitive transcranial magnetic stimulation on motor function recovery after acute ischaemic stroke. Acta Neurol Scand 2009; [Epub ahead of print]
Voce bibliografica Sneed,2008 capitolo 18
18.Sneed,2008 - Sneed JR, Rindskopf D, Steffens GC, Krishnan KR, Roose SP
Sneed JR, Rindskopf D, Steffens GC, Krishnan KR, Roose SP. The vascular depression subtype: evidence of internal validity. Biol Psychiatry 2008; 15: 491-497.
Voce bibliografica Robinson,2005 capitolo 18
18.Robinson,2005 - Robinson RG
Robinson RG. Vascular depression and post-stroke depression. Where do we go from here? Am J Geriatr Psychiatry 2005; 13: 85-87.
Voce bibliografica Hackett,2009 capitolo 18
18.Hackett,2009 - Hackett ML, Anderson CS, House A, Xia J
Hackett ML, Anderson CS, House A, Xia J. Intervention for treating depression after stroke. Last assessed as up-to-date May 2008. Cochrane Database of Systematic Reviews 2009, Issue 4.
Voce bibliografica Santos,2009 capitolo 18
18.Santos,2009 - Santos M, Kövari E, Gold G, Bozika VP, Hof PR, Bouras C, Giannakopoulos P
Santos M, Kövari E, Gold G, Bozika VP, Hof PR, Bouras C, Giannakopoulos P. The neuroanatomical model of post-stroke depression: toward a change of focus? J Neurol Sci 2009; 283: 158-162.
Voce bibliografica Dichgans,2008 capitolo 18
18.Dichgans,2008 - Dichgans M, Markus HS, Salloway S, Verkkoniemi A, Moline M, Wang Q, Posner H, Chabriat HS
Dichgans M, Markus HS, Salloway S, Verkkoniemi A, Moline M, Wang Q, Posner H, Chabriat HS. Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL. Lancet Neurol 2008; 7:310-318.
Voce bibliografica Benisty,2008 capitolo 18
18.Benisty,2008 - Benisty S, Hernandez K, Viswanathan A, Reyes S, Kurtz A, O’Sullivan M, Bousser MG, Dichgans M, Chabriat H
Benisty S, Hernandez K, Viswanathan A, Reyes S, Kurtz A, O’Sullivan M, Bousser MG, Dichgans M, Chabriat H. Diagnostic criteria of vascular dementia in CADASIL. Stroke 2008; 39:838-844.
Voce bibliografica Kavirajan,2007 capitolo 18
18.Kavirajan,2007 - Kavirajan H, Schneider L
Kavirajan H, Schneider L. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials. Lancet Neurol 2007; 6:782-792.
Voce bibliografica Stephan,2009 capitolo 18
18.Stephan,2009 - Stephan BCM, Matthews FE, Kaw K-T, Dufouil C, Brayne C
Stephan BCM, Matthews FE, Kaw K-T, Dufouil C, Brayne C. Beyond mild cognitive impairment: vascular cognitive impairment, no dementia (VCIND). Alzheimer Res Therapy 2009; 1; 4 (doi: 10.1186/alzrt4).
Voce bibliografica Nitkunan,2008 capitolo 18
18.Nitkunan,2008 - Nitkunan A, Barrick TR, Charlton RA, Clark CA, Markus HS
Nitkunan A, Barrick TR, Charlton RA, Clark CA, Markus HS. Multimodal MRI in cerebral small vessel disease: its relationship with cognition and sensitivity to change over time. Stroke 2008; Jul 39(7):1999-2005.
Voce bibliografica Senióv,2009 capitolo 18
18.Senióv,2009 - Senióv J, Litwin M, Litwin T, Leśniak M, Czìronkowska A
Senióv J, Litwin M, Litwin T, Leśniak M, Czìronkowska A. New approach to the rehabilitation of post-stroke focal cognitive syndrome: effect of levo-dopa combined with speech and language therapy on functional recovery from aphasia. J Neurol Sci 2009; 283: 214-218.
Voce bibliografica Bakheit,2007 capitolo 18
18.Bakheit,2007 - Bakheit AM, Shaw S, Barrett L, Wood J, Carrington S, Griffiths S, Searle K, Koutsi F
Bakheit AM, Shaw S, Barrett L, Wood J, Carrington S, Griffiths S, Searle K, Koutsi F. A prospective, randomized, parallel group, controlled study of the effect of intensity of speech and language therapy on early recovery from poststroke aphasia. Clin Rehab 2007; 21: 885-894.
Voce bibliografica Eaton,2008 capitolo 18
18.Eaton,2008 - Eaton KP, Szaflarski JP, Altave M, Ball AL, Kissela BM, Banks C, Holland SK
Eaton KP, Szaflarski JP, Altave M, Ball AL, Kissela BM, Banks C, Holland SK. Reliability of fMRI for studies of language in post-stroke aphasia subjects. Neuroimage 2008; 41: 311-322.
Voce bibliografica Crinion,2007 capitolo 18
18.Crinion,2007 - Crinion JT, Leff AP
Crinion JT, Leff AP. Recovery and treatment of aphasia afeter stroke: functional imaging studies. Curr Opin Neurol 2007; 20: 667-673.
Voce bibliografica Sachdev,2009 capitolo 18
18.Sachdev,2009 - Sachdev PS, Chen X, Brodaty H, Thompson C, Altendorf A, Wen W
Sachdev PS, Chen X, Brodaty H, Thompson C, Altendorf A, Wen W. The determinants and longitudinal course of post-stroke mild cognitive impairment. J Int Neuropsychol Soc 2009; 15: 915-923.
Voce bibliografica Sachdev,2007 capitolo 18
18.Sachdev,2007 - Sachdev PS, Chen X, Joscelyne A, Wen W, Altendorf A, Brodaty H
Sachdev PS, Chen X, Joscelyne A, Wen W, Altendorf A, Brodaty H. Hippocampal size and dementia in stroke patients: the Sydney stroke study. J Neurol Sci 2007; 260:71-77.
Voce bibliografica Reitz,2008 capitolo 18
18.Reitz,2008 - Reitz C, Bos MJ, Hofman A, Koudstaal PJ, Breteler MM
Reitz C, Bos MJ, Hofman A, Koudstaal PJ, Breteler MM. Prestroke cognitive performance, incident stroke, and risk of dementia: the Rotterdam study. Stroke 2008; 39:36-41.
Voce bibliografica Pendlebury,2009 capitolo 18
18.Pendlebury,2009 - Pendlebury ST, Rothwell PM
Pendlebury ST, Rothwell PM. Prevalence, incidence and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol 2009; 8: 1006-1018.
Voce bibliografica Regione-Veneto,2008 capitolo 18
18.Regione-Veneto,2008 - Regione Veneto
DGR 4198 del 30.12.2008 della Regione Veneto. Istituzione della rete integrata per la gestione e il trattamento dell’ictus in fase acuta nella Regione Veneto.
Voce bibliografica Regione-Lombardia,2008 capitolo 18
18.Regione-Lombardia,2008 - Regione Lombardia
DDGS 10068 del 18.9.2008 della Regione Lombardia. Determinazioni in merito all'organizzazione in rete e criteri di riconoscimento delle unità di cura cerebrovascolari (UCV-Stroke Unit).
Voce bibliografica Andaluz,2009 capitolo 18
18.Andaluz,2009 - Andaluz N, Zuccarello M
Andaluz N, Zuccarello M. Recent trends in the treatment of spontaneous intracerebral hemorrhage: analysis of a nationwide inpatient database. J Neurosurg 2009; 110: 403-417.
Voce bibliografica King,2009 capitolo 18
18.King,2009 - King A, Markus HS
King A, Markus HS. Doppler embolic signals in cerebrovascular disease and prediction of stroke risk: a systematic review and meta-analysis. Stroke 2009; 40: 3711-3717.
Voce bibliografica Abbot,2009 capitolo 18
18.Abbot,2009 - Abbot AL
Abbot AL. Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis. Stroke 2009; 40: 573-583.
Voce bibliografica Pappada-G,2009 capitolo 18
18.Pappada-G,2009 - Pappada G, Cesana C, Pirovano M, Vergani F, Parolin M, Pirillo D, Pirola E, Santoro P, Ferrarese C, Sganzerla E
Pappada G, Cesana C, Pirovano M, Vergani F, Parolin M, Pirillo D, Pirola E, Santoro P, Ferrarese C, Sganzerla E. Venous outflow as a criterion of impairment of the cerebral vascular reserve. J Neurosurg Sciences 2009; 53: 101-105.
Voce bibliografica Pappadà,2009 capitolo 18
18.Pappadà,2009 - Pappadà G, Vergani F, Parolin M, Cesana C, Pirovano M, Pirillo D, Santoro P, Landi A, Ferrarese C
Pappadà G, Vergani F, Parolin M, Cesana C, Pirovano M, Pirillo D, Santoro P, Landi A, Ferrarese C. Early acute hemispheric stroke after carotid endarterectomy. Pathogenesis and treatment. Acta Neurochir 2009; [Epub ahead of print]
Voce bibliografica Garbagnati,2009 capitolo 18
18.Garbagnati,2009 - Garbagnati F, Cairella G, De Martino A, Multari M, Scognamiglio U, Venturiero V, Paolucci S
Garbagnati F, Cairella G, De Martino A, Multari M, Scognamiglio U, Venturiero V, Paolucci S. Is Antioxidant and n–3 Supplementation Able to Improve Functional Status in Poststroke Patients? Results from the Nutristroke Trial. Cerebrovasc Dis 2009;27:375–383.
Voce bibliografica Aquilani,2008 capitolo 18
18.Aquilani,2008 - Aquilani R; Scocchi M; Iadarola P; Franciscone P; Verri M; Boschi F; Pasini E; Viglio S
Aquilani R; Scocchi M; Iadarola P; Franciscone P; Verri M; Boschi F; Pasini E; Viglio S. Protein supplementation may enhance the spontaneous recovery of neurological alterations in patients with ischaemic stroke. Clini rehabil 2008;22(12):1042-50.
Voce bibliografica Foley,2009 capitolo 18
18.Foley,2009 - Foley NC, Martin RE, Salter KL, Teasell RW
Foley NC, Martin RE, Salter KL, Teasell RW. A review of the relationship between dysphagia and malnutrition following stroke. J Rehabil Med 2009; 41: 707-713.
Voce bibliografica Kotseva,2009 capitolo 6
6.Kotseva,2009 - Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U
Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U; EUROASPIRE Study Group. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 2009;373(9667):929-40.
Voce bibliografica Wild,2006 capitolo 6
6.Wild,2006 - Wild SH, Byrne CD, Smith FB, Lee AJ, Fowkes FG.
Wild SH, Byrne CD, Smith FB, Lee AJ, Fowkes FG. Low ankle-brachial pressure index predicts increased risk of cardiovascular disease independent of the metabolic syndrome and conventional cardiovascular risk factors in the Edinburgh Artery Study. Diabet Care 2006; 29: 637–642.
Voce bibliografica Weimar,2007 capitolo 6
6.Weimar,2007 - Weimar C, Goertler M, Rother J et al.
Weimar C, Goertler M, Rother J et al. Systemic Risk Score Evaluation in Ischemic Stroke Patients (SCALA). a prospective cross sectional study in 85 German stroke units. J Neurol 2007; 254: 1562–1568.
Voce bibliografica VanWijk,2005 capitolo 6
6.VanWijk,2005 - Van Wijk I, Kappelle LJ, van Gijn J, Koudstaal PJ, Franke CL, Vermeulen M, Gorter JW, Algra A; LiLAC study group
Van Wijk I, Kappelle LJ, van Gijn J, Koudstaal PJ, Franke CL, Vermeulen M, Gorter JW, Algra A; LiLAC study group. Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study. Lancet 2005; 365: 2098–2094.
Voce bibliografica Terent,2004 capitolo 6
6.Terent,2004 - Terent A.
Terent A. Cerebrovascular mortality 10 years after stroke: a population-based study. Stroke 2004; 35: e343–e345.
Voce bibliografica Steg,2007 capitolo 6
6.Steg,2007 - Steg PG, Bhatt DL, Wilson PW, D'Agostino R Sr, Ohman EM, Röther J, Liau CS, Hirsch AT, Mas JL, Ikeda Y, Pencina MJ, Goto S; REACH Registry Investigators
Steg PG, Bhatt DL, Wilson PW, D'Agostino R Sr, Ohman EM, Röther J, Liau CS, Hirsch AT, Mas JL, Ikeda Y, Pencina MJ, Goto S; REACH Registry Investigators. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007; 297: 1197-1206.
Voce bibliografica Agnelli,2006 capitolo 6
6.Sen,2009 - Sen S, Lynch DR, Kaltsas E, Simmons J, Tan WA, Kim J, Beck J, Rosamond W.
Sen S, Lynch DR, Kaltsas E, Simmons J, Tan WA, Kim J, Beck J, Rosamond W. Association of asymptomatic peripheral arterial disease with vascular events in patients with stroke or transient ischemic attack. Stroke 2009; 40: 3472-3477
Voce bibliografica Agnelli,2006 capitolo 6
6. Heald,2006 - Heald CL, Fowkes FGR, Murray GD, Price JF.
Heald CL, Fowkes FGR, Murray GD, Price JF. Risk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review. Atherosclerosis 2006; 189: 61– 69.
Voce bibliografica Valham,2008 capitolo 6
6.Gongora-Rivera,2007 - Gongora-Rivera F, Labreuche J, Jaramillo A, Steg PG, Hauw JJ, Amarenco P
Gongora-Rivera F, Labreuche J, Jaramillo A, Steg PG, Hauw JJ, Amarenco P: Autopsy prevalence of coronary atherosclerosis in patients with fatal stroke. Stroke 2007; 38: 1203–1210.
Voce bibliografica Diehm,2009 capitolo 6
6.Diehm,2009 - Diehm C, Allenberg JR, Pittrow D, Mahn M, Tepohl G, Haberl RL, Dairus H, Dipl-Math IB, Trampisch HJ
Diehm C, Allenberg JR, Pittrow D, Mahn M, Tepohl G, Haberl RL, Dairus H, Dipl-Math IB, Trampisch HJ.c
Voce bibliografica Carolei,2006 capitolo 6
6.Carolei,2008 - Carolei A, Chamorro A, Laloux P, Leys D, Röther J, Sander D, Stansby G, Weimar C.
Carolei A, Chamorro A, Laloux P, Leys D, Röther J, Sander D, Stansby G, Weimar C. Identification and management of polyvascular disease in patients with noncardioembolic ischaemic stroke. Int J Stroke 2008; 3: 237-248.
Voce bibliografica Busch,2009 capitolo 6
6.Busch,2009 - Busch MA, Lutz K; Röhl J-E, Neuner B, Masuhr F.
Busch MA, Lutz K; Röhl J-E, Neuner B, Masuhr F. Low Ankle-Brachial Index predicts cardiovascular risk after acute ischemic stroke or transient ischemic attack. Stroke 2009; 40: 3700-3705.
Voce bibliografica Bhatt,2006 capitolo 6
6.Bhatt,2006 - Bhatt DL, Steg PG, Ohman EM et al.
Bhatt DL, Steg PG, Ohman EM et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006; 295: 180–189.
Voce bibliografica AnkleBrachialIndexCollaboration,2008 capitolo 6
6.AnkleBrachialIndexCollaboration,2008 - Ankle Brachial Index Collaboration
Ankle Brachial Index Collaboration. Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008; 300: 197–208.
Voce bibliografica Agnelli,2006 capitolo 6
6.Agnelli,2006 - Agnelli G, Cimminiello C, Meneghetti G, Urbinati S.
Agnelli G, Cimminiello C, Meneghetti G, Urbinati S. Low ankle-brachial index predicts an adverse 1-year outcome after acute coronary and cerebrovascular events. J Thromb Haemost 2006; 4: 2599–2606.
Adams RJ, Chimowitz MI, Alpert JS et al.
6.Adams,2003 - Adams RJ, Chimowitz MI, Alpert JS et al.
Adams RJ, Chimowitz MI, Alpert JS et al. Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. Circulation 2003; 108: 1278–1290.
Voce bibliografica Valham,2008 capitolo 6
6.Valham,2008 - Valham F, Mooe T, Rabben T, Stenlund H, Wiklund U, Franklin KA.
Valham F, Mooe T, Rabben T, Stenlund H, Wiklund U, Franklin KA. Increased risk of stroke in patients with coronary artery disease and sleep apnea: a 10-year follow-up. Circulation 2008; 118: 955-960.
Voce bibliografica Somers,2008 capitolo 6
6.Somers,2008 - Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, Daniels S, Floras JS, Hunt CE, Olson LJ, Pickering TG, Russell R, Woo M, Young T; American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology; American Heart Association Stroke Council; American Heart Association Council on Cardiovascular Nursing; American College of Cardiology Foundation
Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, Daniels S, Floras JS, Hunt CE, Olson LJ, Pickering TG, Russell R, Woo M, Young T; American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology; American Heart Association Stroke Council; American Heart Association Council on Cardiovascular Nursing; American College of Cardiology Foundation. Sleep apnea and cardiovascular disease: an American Heart Association/american College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 2008; 118: 1080-1111.
Voce bibliografica ,Sahlin,2008 capitolo 6
6.Sahlin,2008 - Sahlin C, Sandberg O, Gustafson Y, Bucht G, Carlberg B, Stenlund H, Franklin KA.
Sahlin C, Sandberg O, Gustafson Y, Bucht G, Carlberg B, Stenlund H, Franklin KA. Obstructive sleep apnea is a risk factor for death in patients with stroke. Arch Intern Med 2008; 168: 297-301.
Voce bibliografica Schürks,2009 capitolo 6
6.Schürks,2009 - Schürks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T.
Schürks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ 2009; 339: b3914.
Voce bibliografica Sacco,2010 capitolo 6
6.Sacco,2010 - Sacco S, Carolei A. Migraine
Sacco S, Carolei A. Migraine: an emerging cardiovascular risk factor. Cardiol Clin Practice 2010; 2: 1-13.
Voce bibliografica Sacco,2008 capitolo 6
6.Sacco,2008 - Sacco S, Cerone D, Carolei A.
Sacco S, Cerone D, Carolei A. Comorbid neuropathologies in migraine: an update on cerebrovascular and cardiovascular aspects. J Headache Pain 2008; 9: 237-248.
Voce bibliografica Chiuve,2008 capitolo 18
18.Chiuve,2008 - Chiuve SE, Rexrode KM, Spiegelman D, Logroscino G, Manson JE, Rimm EB
Chiuve SE, Rexrode KM, Spiegelman D, Logroscino G, Manson JE, Rimm EB. Primary prevention of stroke by healthy lifestyle. Circulation 2008; 118: 947–954.
Voce bibliografica Fung,2009 capitolo 18
18.Fung,2009 - Fung TT, Rexrode KM, Mantzoros CS, Manson JE, Willett WC, Hu FB
Fung TT, Rexrode KM, Mantzoros CS, Manson JE, Willett WC, Hu FB. Mediterranean Diet and Incidence of and Mortality From Coronary Heart Disease and Stroke in Women. Circulation 2009; 119: 1093-1100.
Voce bibliografica Fung,2008 capitolo 18
18.Fung,2008 - Fung T, Chiuve SE, McCullough M, Rexrode K, Giancarlo Logroscino G, Hu F
Fung T, Chiuve SE, McCullough M, Rexrode K, Giancarlo Logroscino G, Hu F. Adherence to a DASH-Style Diet and Risk of Coronary Heart Disease and Stroke in Women. Arch Intern Med 2008; 168: 713-720.
Voce bibliografica Yusuf,2008 capitolo 18
18.Yusuf,2008 - Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P; Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators
Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P; Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. Lancet 2008; 372: 1174-1183.
Voce bibliografica Cowan,2009 capitolo 18
18.Cowan,2009 - Cowan BR, Young AA, Anderson C, Doughty RN, Krittayaphong R, Lonn E, Marwick TH, Reid CM, Sanderson JE, Schmieder RE, Teo K, Wadham AK, Worthley SG, Yu CM, Yusuf S, Jennings GL; ONTARGET Investigators
Cowan BR, Young AA, Anderson C, Doughty RN, Krittayaphong R, Lonn E, Marwick TH, Reid CM, Sanderson JE, Schmieder RE, Teo K, Wadham AK, Worthley SG, Yu CM, Yusuf S, Jennings GL; ONTARGET Investigators. Left ventricular mass and volume with telmisartan, ramipril, or combination in patients with previous atherosclerotic events or with diabetes mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET]). Am J Cardiol 2009; 104: 1484-1489.
Voce bibliografica Ridker,2008 capitolo 18
18.Ridker,2008 - Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Study Group
Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359: 2195-2207.
Voce bibliografica Tsivgoulis,2010 capitolo 18
18.Tsivgoulis,2010 - Tsivgoulis G, Eggers J, Ribo M, Perren F, Saqqur M, Rubiera M, Sergentanis TN, Vadikolias K, Larrue V, Molina CA, Alexandrov AV
Tsivgoulis G, Eggers J, Ribo M, Perren F, Saqqur M, Rubiera M, Sergentanis TN, Vadikolias K, Larrue V, Molina CA, Alexandrov AV. Safety and efficacy of ultrasound-enhanced thrombolysis: a comprehensive review and meta-analysis of randomized and nonrandomized studies. Stroke 2010; 41: 280-287.
Voce bibliografica Wallentin,2009 capitolo 18
18.Wallentin,2009 - Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA; PLATO Investigators, Freij A, Thorsén M
Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA; PLATO Investigators, Freij A, Thorsén M. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009; 361: 1045-1057.
Voce bibliografica Bhatt,2009 capitolo 18
18.Bhatt,2009 - Bhatt DL, Lincoff AM, Gibson CM, Stone GW, McNulty S, Montalescot G, Kleiman NS, Goodman SG, White HD, Mahaffey KW, Pollack CV Jr, Manoukian SV, Widimsky P, Chew DP, Cura F, Manukov I, Tousek F, Jafar MZ, Arneja J, Skerjanec S, Harrington RA; the CHAMPION PLATFORM Investigators
Bhatt DL, Lincoff AM, Gibson CM, Stone GW, McNulty S, Montalescot G, Kleiman NS, Goodman SG, White HD, Mahaffey KW, Pollack CV Jr, Manoukian SV, Widimsky P, Chew DP, Cura F, Manukov I, Tousek F, Jafar MZ, Arneja J, Skerjanec S, Harrington RA; the CHAMPION PLATFORM Investigators. Intravenous Platelet Blockade with Cangrelor during PCI. N Engl J Med 2009; [Epub ahead of print]
Voce bibliografica Harrington,2009 capitolo 18
18.Harrington,2009 - Harrington RA, Stone GW, McNulty S, White HD, Lincoff AM, Gibson CM, Pollack CV Jr, Montalescot G, Mahaffey KW, Kleiman NS, Goodman SG, Amine M, Angiolillo DJ, Becker RC, Chew DP, French WJ, Leisch F, Parikh KH, Skerjanec S, Bhatt DL
Harrington RA, Stone GW, McNulty S, White HD, Lincoff AM, Gibson CM, Pollack CV Jr, Montalescot G, Mahaffey KW, Kleiman NS, Goodman SG, Amine M, Angiolillo DJ, Becker RC, Chew DP, French WJ, Leisch F, Parikh KH, Skerjanec S, Bhatt DL. Platelet Inhibition with Cangrelor in Patients Undergoing PCI. N Engl J Med 2009; [Epub ahead of print]
Voce bibliografica Wiviott,2007 capitolo 18
18.Wiviott,2007 - Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM; TRITON-TIMI 38 Investigators
Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM; TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007; 357: 2001-2015.
Voce bibliografica Weitz,2008 capitolo 18
18.Weitz,2008 - Weitz JI, Hirsh J, Samama MM
Weitz JI, Hirsh J, Samama MM. New antithrombotic drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133(6 Suppl): 234S-256S.
Voce bibliografica Bonello,2008 capitolo 18
18.Bonello,2008 - Bonello L, Camoin-Jau L, Arques S, Boyer C, Panagides D, Wittenberg O, Simeoni MC, Barragan P, Dignat-George F, Paganelli F
Bonello L, Camoin-Jau L, Arques S, Boyer C, Panagides D, Wittenberg O, Simeoni MC, Barragan P, Dignat-George F, Paganelli F. Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study. J Am Coll Cardiol 2008; 51: 1404-1411.
Voce bibliografica Marcucci,2009 capitolo 18
18.Marcucci,2009 - Marcucci R, Gori AM, Paniccia R, Giusti B, Valente S, Giglioli C, Buonamici PG, Antoniucci D, Abbate R, Gensini GF
Marcucci R, Gori AM, Paniccia R, Giusti B, Valente S, Giglioli C, Buonamici PG, Antoniucci D, Abbate R, Gensini GF. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12 month follow-up. Circulation 2009; 119: 237-242.
Voce bibliografica Price,2008 capitolo 18
18.Price,2008 - Price MJ, Endemann S, Gollapudi RR, Valencia R, Stinis CT, Levisay JP, Ernst A, Sawhney NS, Schatz RA, Teirstein PS
Price MJ, Endemann S, Gollapudi RR, Valencia R, Stinis CT, Levisay JP, Ernst A, Sawhney NS, Schatz RA, Teirstein PS. Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation. Eur Heart J 2008; 29: 992-1000.
Voce bibliografica Sibbing,2008 capitolo 18
18.Sibbing,2008 - Sibbing D, Braun S, Jawansky S, Vogt W, Mehilli J, Schömig A, Kastrati A, von Beckerath N
Sibbing D, Braun S, Jawansky S, Vogt W, Mehilli J, Schömig A, Kastrati A, von Beckerath N. Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment. Thromb Haemost 2008; 99: 121-126.
Voce bibliografica Gori,2008 capitolo 18
18.Gori,2008 - Gori AM, Marcucci R, Migliorini A, Valenti R, Moschi G, Paniccia R, Buonamici P, Gensini GF, Vergara R, Abbate R, Antoniucci D
Gori AM, Marcucci R, Migliorini A, Valenti R, Moschi G, Paniccia R, Buonamici P, Gensini GF, Vergara R, Abbate R, Antoniucci D. Incidence and clinical impact of dual nonresponsiveness to aspirin and clopidogrel in patients with drug eluting stents. J Am Coll Cardiol 2008; 52: 734-739.
Voce bibliografica Prisco,2009 capitolo 18
18.Prisco,2009 - Prisco D, Antonucci E, Grifoni E, Mazzaglia G, Bellandi T, Tartaglia R, Poli D
Prisco D, Antonucci E, Grifoni E, Mazzaglia G, Bellandi T, Tartaglia R, Poli D. Different models for oral anticoagulation management may be applied provided that minimal assistance criteria are fulfilled: an Italian experience. Semin Thromb Hemost 2009; 35: 568-573.
Voce bibliografica GRT,2008 capitolo 18
18.GRT,2008 - Giunta Regionale Toscana
Giunta Regionale Toscana. Deliberazione n. 46 - 28 Gennaio 2008. Indirizzi alle aziende sanitarie per la gestione della qualità e della sicurezza nella terapia anticoagulante orale (TAO).
Voce bibliografica Gadisseur,2003 capitolo 18
18.Gadisseur,2003 - Gadisseur AP, Breukink-Engbers WG, van der Meer FJ, van den Besselaar AM, Sturk A, Rosendaal FR
Gadisseur AP, Breukink-Engbers WG, van der Meer FJ, van den Besselaar AM, Sturk A, Rosendaal FR. Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Arch Intern Med 2003; 163: 2639-2646.
Voce bibliografica Cromheecke,2000 capitolo 18
18.Cromheecke,2000 - Cromheecke ME, Levi M, Colly LP, de Mol BJ, Prins MH, Hutten BA, Mak R, Keyzers KC, Büller HR
Cromheecke ME, Levi M, Colly LP, de Mol BJ, Prins MH, Hutten BA, Mak R, Keyzers KC, Büller HR. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet 2000; 356: 97-102.
Voce bibliografica Watzke,2000 capitolo 18
18.Watzke,2000 - Watzke HH, Forberg E, Svolba G, Jimenez-Boj E, Krinninger B
Watzke HH, Forberg E, Svolba G, Jimenez-Boj E, Krinninger B. A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation. Thromb Haemost 2000; 83: 661-665.
Voce bibliografica Jowett,2009 capitolo 18
18.Jowett,2009 - Jowett S, Bryan S, Poller L, VAN DEN Besselaar AM, VAN DER Meer FJ, Palareti G, Shiach C, Tripodi A, Keown M, Ibrahim S, Lowe G, Moia M, Turpie AG, Jespersen J
Jowett S, Bryan S, Poller L, VAN DEN Besselaar AM, VAN DER Meer FJ, Palareti G, Shiach C, Tripodi A, Keown M, Ibrahim S, Lowe G, Moia M, Turpie AG, Jespersen J. The cost-effectiveness of computer-assisted anticoagulant dosage: results from the European Action on Anticoagulation (EAA) multicentre study. J Thromb Haemost 2009; 7: 1482-1490.
Voce bibliografica Poller,2009 capitolo 18
18.Poller,2009 - Poller L, Keown M, Ibrahim S, Lowe G, Moia M, Turpie AG, Roberts C, van den Besselaar AM, van der Meer FJ, Tripodi A, Palareti G, Shiach C, Bryan S, Samama M, Burgess-Wilson M, Heagerty A, Maccallum P, Wright D, Jespersen J; European Action on Anticoagulation (EAA).
Poller L, Keown M, Ibrahim S, Lowe G, Moia M, Turpie AG, Roberts C, van den Besselaar AM, van der Meer FJ, Tripodi A, Palareti G, Shiach C, Bryan S, Samama M, Burgess-Wilson M, Heagerty A, Maccallum P, Wright D, Jespersen J; European Action on Anticoagulation (EAA). A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program. Thromb Haemost 2009; 101: 487-494.
Voce bibliografica Poller-L,2008 capitolo 18
18.Poller-L,2008 - Poller L, Keown M, Ibrahim S, Lowe G, Moia M, Turpie AG, Roberts C, van den Besselaar AM, van der Meer FJ, Tripodi A, Palareti G, Jespersen J
Poller L, Keown M, Ibrahim S, Lowe G, Moia M, Turpie AG, Roberts C, van den Besselaar AM, van der Meer FJ, Tripodi A, Palareti G, Jespersen J. A multicentre randomised clinical endpoint study of PARMA 5 computer-assisted oral anticoagulant dosage. Br J Haematol 2008; 143: 274-283.
Voce bibliografica Poller,2008 capitolo 18
18.Poller,2008 - Poller L, Keown M, Ibrahim S, Lowe G, Moia M, Turpie AG, Roberts C, van den Besselaar AM, van der Meer FJ, Tripodi A, Palareti G, Shiach C, Bryan S, Samama M, Burgess-Wilson M, Heagerty A, Maccallum P, Wright D, Jespersen J
Poller L, Keown M, Ibrahim S, Lowe G, Moia M, Turpie AG, Roberts C, van den Besselaar AM, van der Meer FJ, Tripodi A, Palareti G, Shiach C, Bryan S, Samama M, Burgess-Wilson M, Heagerty A, Maccallum P, Wright D, Jespersen J. An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage. J Thromb Haemost 2008; 6: 935-943.
Voce bibliografica Crowther,2009 capitolo 18
18.Crowther,2009 - Crowther MA, Ageno W, Garcia D, Wang L, Witt DM, Clark NP, Blostein MD, Kahn SR, Vesely SK, Schulman S, Kovacs MJ, Rodger MA, Wells P, Anderson D, Ginsberg J, Selby R, Siragusa S, Silingardi M, Dowd MB, Kearon C
Crowther MA, Ageno W, Garcia D, Wang L, Witt DM, Clark NP, Blostein MD, Kahn SR, Vesely SK, Schulman S, Kovacs MJ, Rodger MA, Wells P, Anderson D, Ginsberg J, Selby R, Siragusa S, Silingardi M, Dowd MB, Kearon C. Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial. Ann Intern Med 2009; 150: 293-300.
Voce bibliografica Douketis,2008 capitolo 18
18.Douketis,2008 - Douketis J, Cook D, Meade M, Guyatt G, Geerts W, Skrobik Y, Albert M, Granton J, Hébert P, Pagliarello G, Marshall J, Fowler R, Freitag A, Rabbat C, Anderson D, Zytaruk N, Heels-Ansdell D, Crowther M
Douketis J, Cook D, Meade M, Guyatt G, Geerts W, Skrobik Y, Albert M, Granton J, Hébert P, Pagliarello G, Marshall J, Fowler R, Freitag A, Rabbat C, Anderson D, Zytaruk N, Heels-Ansdell D, Crowther M. Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin: an assessment of safety and pharmacodynamics: the DIRECT study. Arch Intern Med 2008; 168: 1805-1812.